Printer Friendly

Articles from M2 Pharma (June 1, 2020)

1-42 out of 42 article(s)
Title Author Type Words
AbbVie partners with Jacobio to advance SHP2 Inhibitors to reduce cancer cell growth and generate anti-tumour activity. 223
AcelRx Pharmaceuticals amends merger agreement to acquire Tetraphase Pharmaceuticals. 167
ADP Research Survey Uncovers COVID-19 Impact on US Workforce, Worker Confidence. 340
Allied Market Research Reports Industry Forecast of COVID-19 Diagnostics Market. Industry overview 337
Apollo Hospitals Group Integrates Zebra Medical Vision's AI for COVID-19 Detection and Disease Progression Tracking. 405
ATC launches turn-key onsite COVID-19 testing services following reopening of business during the pandemic. 217
Australia enters Stage 2 of COVID-19 lockdown with extensive relaxation of restrictions; Only 21 COVID-19 cases in hospital. 171
Cigna Extends Relief Efforts to Holders of Medicare Advantage, Individual and Family Plans for COVID-19. 185
Codiak BioSciences Collaborates with Ragon Institute to Evaluate the exoVACC Vaccine Platform in SARS-CoV-2 and HIV. 565
COVID-19 restrictions put pressure on UK restaurants. 188
CTI BioPharma Enrolls 1st Patient in COVID-19 PRE-VENT Trial. Clinical report 209
Datos Health Partners with Strategic Interests to Contain Spread of COVID-19 in Upstate New York. 301
Decorating with Fabric unveils clear vinyl protective Screen Application B-Shield to face the ongoing health and safety challenges of re-opening businesses during the COVID-19. 195
Elekta's 2019/20 results impacted in Q4 due to COVID-19 effects. Financial report 265
FDA Accepts Shionogi's Supplemental New Drug Application with Priority Review for Fetroja for the Treatment of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia. 372
FDA Authorises Emergency Use of Confirm BioSciences' COVID-19 Test Kit. 161
FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients with Right Heart Failure. 557
India's capital will close its borders for a week to contain spread of COVID-19. 204
Iran's government warns of risk of 'stronger' second wave of COVID-19 if guidelines ignored. 221
Japan considers allowing visitors after border closure due to COVID-19 pandemic. 169
LabCorp Launches New COVID-19 Clinical Trial Site to Connect Patients with US Research Trials. 188
Long queues seen outside Ikea as it reopens in England after COVID-19 lockdown. 162
Mexico to commence re-opening after COVID-19 lockdown from 1 June 2020. 155
Mixology Clothing Company to use BIOPROTECTUs System to disinfect retail locations in Manhattan, Westchester, New Jersey and Long Island for reopening during the COVID-19 pandemic. 200
Moscow eases COVID-19 lockdown restrictions. 200
NASA announces eight US companies to manufacture new VITAL ventilator tailored for COVID-19 patients. 281
North Korea to reopen schools only in early June 2020 despite claiming no COVID-19 infection cases. 169
NRL chemists reports shipboard decontamination strategy. 175
NYU Langone Enrolls Patients in Clinical Trial for COVID-19 Antibody Therapy. 300
Optomed's Q1 2020 results affected by COVID-19 pandemic especially in Devices segment. Financial report 225
Phio Pharmaceuticals reveals positive data from in vivo studies on the intratumoral use of INTASYL Compounds. 221
RDIF and Avifavir ChemRar Group to deliver first Russian Favipiravir-based drug for COVID-19 treatment. 240
Research Finds Decline in Growth of AI in Construction Market During COVID-19 Crisis. 247
Sema4 to Deliver High Capacity COVID-19 Testing in Partnership with the State of Connecticut. 421
South Africa delays reopening of schools after COVID-19 lockdown to get ready. 153
SwabTek unveils the Buy One, Give One programme to donate protective masks to law enforcement offices during COVID-19 crisis. 152
Tallink Grupp's loan agreements amended to face challenges due to COVID-19 pandemic. 152
Twist Bioscience to Join Proteona in Global Alliance to Protect Immunocompromised Patients From COVID-19 Infection. 641
US FDA grants approval to Menlo Therapeutics' ZILXI topical foam, 1.5%. 195
Vizient's Novaplus Enhanced Supply Program Enabled Access to 676,000 Additional Units of Propofol as COVID-19 Cases Surged. Drug overview 397
Well Beyond Tech Company Launches Free App to Combat COVID-19 in Developing World. 227
Xspray Pharma commences pivotal bioequivalence studies with HyNap-Dasa aimed at US market approval. 178

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters